Clinical Trial Update: Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating micafungin prophylaxis during first induction chemotherapy in de novo acute leukemia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Micafungin (micafungin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Acute Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-11-09